Coya Therapeutics, Inc.
COYA
$6.15
$0.172.84%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.29% | -101.38% | -66.31% | -86.29% | 13.45% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.91% | 102.60% | 95.06% | 89.93% | -9.24% |
| Change in Net Operating Assets | 199.62% | -88.59% | -143.00% | 140.40% | -26.71% |
| Cash from Operations | -19.98% | -139.61% | -194.70% | 8.04% | 9.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -136.48% | 100.00% | 100.00% | 95.40% | 70.51% |
| Cash from Investing | -136.48% | 100.00% | 100.00% | 95.40% | 70.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -68.30% | -68.37% | -41.83% | -57.80% | 115.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | -- | -26.71% |
| Cash from Financing | -68.11% | -68.41% | -41.75% | -58.29% | 115.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.51% | -129.05% | -102.33% | -78.60% | 802.31% |